Related sites
#credit
#credit report
#credit score
#credit reports
#business
#credit history
#credit card
#credit monitoring
#credit cards
#cibil score
#cibil login
#cibil score check
#check cibil score
Malware Scan Info
Macafee Check :
Email address with cibinqo.com
Recent Searched Sites
Debolivia.info (4 seconds ago) / US
Inspire.org (5 seconds ago) / US
Bablhost.com (6 seconds ago) / US
Sendeyim.net (6 seconds ago) / TR
Irtotalplay.mx (3 seconds ago) / US
Axisfamilycare.com (2 seconds ago) / US
Phxapartments.com (35 seconds ago) / US
Mcourser.ph (1 seconds ago) / MX
Smbinaction.com (7 seconds ago) / US
Limsama.com (4 seconds ago) / ES
Clio.one (11 seconds ago) / US
Eroeronavi.com (27 seconds ago) / JP
Westernoregonhorseproperties.com (4 seconds ago) / US
Solowski.info (1 mins ago) / US
Naenohattori.com (1 seconds ago) / JP
Innobiomax.com (7 seconds ago) / CN
Cibinqo.com (0 seconds ago) / US
Torsineen.com (0 seconds ago) / AU
Foregene.com (34 seconds ago) / CN
Tac-dung-hat-dieu.xyz (25 seconds ago) / MX
Domain Informations
Cibinqo.com lookup results from whois.comlaude.com server:
- Domain created: 2009-05-06T19:00:07Z
- Domain updated: 2023-05-22T05:20:06Z
- Domain expires: 2026-05-06T19:00:07Z 2 Years, 39 Days left
- Website age: 14 Years, 325 Days
- Registrar Domain ID: 1554681894_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- NS1.P201.DNS.ORACLECLOUD.NET
- NS2.P201.DNS.ORACLECLOUD.NET
- NS3.P201.DNS.ORACLECLOUD.NET
- NS4.P201.DNS.ORACLECLOUD.NET
Network
- inetnum : 172.64.0.0 - 172.71.255.255
- name : CLOUDFLARENET
- handle : NET-172-64-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 712800 |
networksolutions.com | 276476 |
namecheap.com | 252855 |
tucows.com | 147118 |
publicdomainregistry.com | 113996 |
whois.godaddy.com | 80987 |
enomdomains.com | 63199 |
namesilo.com | 58431 |
gmo.jp | 55777 |
cloudflare.com | 52888 |
register.com | 49752 |
domains.google.com | 47191 |
fastdomain.com | 41448 |
ionos.com | 38149 |
net.cn | 36482 |
name.com | 36228 |
registrar.amazon.com | 34066 |
wildwestdomains.com | 33736 |
key-systems.net | 32656 |
Host Informations
Host name | 172.64.152.241 |
IP address | 172.64.152.241 |
Location | United States |
Latitude | 37.751 |
Longitude | -97.822 |
Timezone | America/Chicago |
Port Scanner (IP: 172.64.152.241)
Spam Check (IP: 172.64.152.241) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Overview & More informations
Cibinqo (abrocitinib) is a once-daily, oral JAK inhibitor indicated for the treatment of moderate-to-severe atopic dermatitis (AD) in adults who are candidates for systemic therapy. Cibinqo is not recommended for use in children under 12 years of age.
Cibinqo was developed by Pfizer and is marketed by AbbVie. It was approved by the U.S. Food and Drug Administration (FDA) in January 2022.
Cibinqo is available in 100 mg and 200 mg tablets. The recommended starting dose is 100 mg once daily, which can be increased to 200 mg once daily if needed.
Cibinqo is generally well-tolerated. The most common side effects include headache, nausea, diarrhea, and fatigue.
Cibinqo is a new and effective treatment for moderate-to-severe AD. It is a once-daily, oral medication that is generally well-tolerated.
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
eastjapanlighting.com | brdomain.jp | 232 Days |
shaqtoberfest.com | godaddy.com | Expired |
amiplaw.com | tucows.com | 141 Days |
cupcakemag.com | register.com | 97 Days |
avatarity.com | godaddy.com | 148 Days |
openstemcelljournal.com | registrar.amazon.com | 322 Days |
bunny-open.com | tucows.com | 122 Days |
barkoda.com | godaddy.com | 256 Days |
network-switch-log-monitoring.org | enom.com | 11 Days |
hrbhaochang.com | xinnet.com | 333 Days |